Veradermics Inc (MANE)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Veradermics Inc-Aktie (MANE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
Operating Expenses	1.03% 29.55	29.86
Operating Income/Loss	1.03% -29.55	-29.86
Nonoperating Income/Loss	130.08% 6.051	2.63
Income/Loss From Continuing Operations Before Tax	13.70% -23.50	-27.23
Income Tax Expense/Benefit	-	-
Net Income/Loss	13.70% -23.50	-27.23
Basic Average Shares	78.10% 40.44	22.70
Diluted Average Shares	78.10% 40.44	22.70
Basic Earnings Per Share	56.06% -0.58	-1.32
Diluted Earnings Per Share	56.06% -0.58	-1.32

ORKA

$73.87

3.66%

SRRK

$40.64

2.63%

TVTX

$52.79

0.90%

CRSP

$51.52

2.59%

DFTX

$34.26

0.06%

PTCT

$60.99

2.21%